These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3143361)

  • 81. Sphingolipids of human umbilical cord vein and their alteration in preeclampsia.
    Romanowicz L; Bańkowski E
    Mol Cell Biochem; 2010 Jul; 340(1-2):81-9. PubMed ID: 20155487
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Stimulation of erythroblast maturation in vitro by sphingolipids.
    Clayton RB; Cooper JM; Curstedt T; Sjövall J; Borsook H; Chin J; Schwarz A
    J Lipid Res; 1974 Nov; 15(6):557-62. PubMed ID: 4372286
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dietary Fat and Protein Intake in Relation to Plasma Sphingolipids as Determined by a Large-Scale Lipidomic Analysis.
    Seah JYH; Chew WS; Torta F; Khoo CM; Wenk MR; Herr DR; Tai ES; van Dam RM
    Metabolites; 2021 Feb; 11(2):. PubMed ID: 33567768
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Lipid transport during mitosis. Alternative pathways for delivery of newly synthesized lipids to the cell surface.
    Kobayashi T; Pagano RE
    J Biol Chem; 1989 Apr; 264(10):5966-73. PubMed ID: 2925644
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Sphingomyelin synthesis in Fasciola hepatica.
    Bankov I; Barrett J
    Int J Parasitol; 1990 Aug; 20(5):581-5. PubMed ID: 2228421
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Metabolic fate of exogenous sphingosine in neuroblastoma neuro2A cells. Dose-dependence and biological effects.
    Riboni L; Bassi R; Caminiti A; Prinetti A; Viani P; Tettamanti G
    Ann N Y Acad Sci; 1998 Jun; 845():46-56. PubMed ID: 9668342
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evidence for de novo sphingolipid biosynthesis in Toxoplasma gondii.
    Azzouz N; Rauscher B; Gerold P; Cesbron-Delauw MF; Dubremetz JF; Schwarz RT
    Int J Parasitol; 2002 Jun; 32(6):677-84. PubMed ID: 12062486
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins.
    Iqbal J; Al Qarni A; Bakillah A
    Adv Exp Med Biol; 2022; 1372():57-65. PubMed ID: 35503174
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of puromycin on the incorporation of erythro DL-(3H)sphingosine into sphingolipids in vivo.
    Kanfer JN; Bradley RM; Gal AE
    J Neurochem; 1967 Nov; 14(11):1095-8. PubMed ID: 6066075
    [No Abstract]   [Full Text] [Related]  

  • 90. Chemistry and biochemistry of sphingosine bases.
    Stoffel W
    Chem Phys Lipids; 1973 Dec; 11(4):318-34. PubMed ID: 4772653
    [No Abstract]   [Full Text] [Related]  

  • 91. Endogenous sphingolipid metabolites related to the growth in Sphingomonas chungbukensis.
    Burenjargal M; Lee YS; Yoo JM; Kim YC; Lee YM; Oh S; Yun YP; Hong JT; Chung YB; Moon DC; Yoo HS
    Arch Pharm Res; 2007 Mar; 30(3):317-22. PubMed ID: 17424937
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Identification of ammonium ion and 2,6-bis(omega-aminobutyl)- 3, 5-diiminopiperazine as endogenous factors that account for the "burst" of sphingosine upon changing the medium of J774 cells in culture.
    Warden LA; Menaldino DS; Wilson T; Liotta DC; Smith ER; Merrill AH
    J Biol Chem; 1999 Nov; 274(48):33875-80. PubMed ID: 10567348
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Indirect Lipid Transfer Protein Activity Measurements Using Quantification of Glycosphingolipid Production.
    Backman APE; Halin J; Kjellberg MA; Mattjus P
    Methods Mol Biol; 2019; 1949():105-114. PubMed ID: 30790252
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mass spectra of complex molecules. I. Chemical ionization of sphingolipids.
    Markey SP; Wenger DA
    Chem Phys Lipids; 1974 May; 12(3):182-200. PubMed ID: 4366088
    [No Abstract]   [Full Text] [Related]  

  • 95. Synthesis of key precursors of radiolabeled sphingolipids.
    Bielawska A; Szulc Z; Hannun YA
    Methods Enzymol; 2000; 311():518-35. PubMed ID: 10563347
    [No Abstract]   [Full Text] [Related]  

  • 96. Use of short-chain ceramides.
    Luberto C; Hannun YA
    Methods Enzymol; 2000; 312():407-20. PubMed ID: 11070889
    [No Abstract]   [Full Text] [Related]  

  • 97. Sphingolipids in vascular biology.
    Argraves KM; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2002; 507():439-44. PubMed ID: 12664623
    [No Abstract]   [Full Text] [Related]  

  • 98. "Fix and assay": separating in-cellulo sphingolipid reactions from analytical assay in time and space using an aldehyde-based fixative.
    Proctor A; Allbritton NL
    Analyst; 2019 Jan; 144(3):961-971. PubMed ID: 30207332
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Physiological and pathological roles of bioactive sphingolipids.
    Bruni P; Donati C
    Cell Signal; 2021 Oct; 86():110102. PubMed ID: 34332071
    [No Abstract]   [Full Text] [Related]  

  • 100. Suppression of de novo sphingolipid biosynthesis mitigates sarcopenia.
    Miranda ER; Funai K
    Nat Aging; 2022 Dec; 2(12):1088-1089. PubMed ID: 37118546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.